Personalized tumor neoantigen mRNA therapy

· Zhejiang University

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Personalized tumor neoantigen mRNA therapy, covering 2025-03-21 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]